Aroa Biosurgery will raise up to A$30 million in an initial public offering across the Tasman to repay debt and expand its sales and manufacturing capacity. The Auckland-based soft-tissue regeneration company's existing shareholders will also sell another A$15 million of stoc...
New Zealand shares fell as a cornerstone investor of Ebos Group sold down a 9 percent stake in the healthcare products company, dominating trading today. Investors also remain concerned about the threat of a second wave of covid-19. The S&P/NZX 50 Index fell 25.88 points, or 0...
The New Zealand dollar ended a roller-coaster day with trading roiled by a White House spokesman appearing to say the US-China trade deal was over and then recovering once US President Donald Trump tweeted that the deal was intact. The kiwi was trading at 64.71 US cents at 5pm...